David Gould, MD
Surgery · Manchester, NHNPI 1821034406
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 85.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $4,512 and has fallen 93.5% since, to $294 in 2025.
Across 20 payments — averaging $286.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Covidien LP$399
- Davol Inc.$178
- Johnson & Johnson$168
- Mentor Worldwide LLC$82
- Endogastric Solutions, Inc$9
What the payments were for
- Consulting fees$2,66346%
- Travel & lodging$2,07336%
- Food & beverage$99117%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $4,891 |
| Covidien LP | 3 | $399 |
| Davol Inc. | 2 | $178 |
| Johnson & Johnson | 4 | $168 |
| Mentor Worldwide LLC | 1 | $82 |
| Endogastric Solutions, Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROTICULATOR$185
- EndoFlip$125
How this compares
$5,727 in reported general payments places this provider in the 70th percentile of 133 surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $2,575 |
| Ursodiol | 25 | $1,073 |
| Omeprazole | 26 | $303 |
| Ondansetron OdtOndansetron | 21 | $100 |
| Oxycodone Hcl | 24 | $50 |
Paid to pharmacies, not to this prescriber.
Other surgery in Manchester
- Andrew WuManchester$16K
- Robert CataniaManchester$9K
- Christopher LundquistManchester$7K
- Patrick MahonManchester$7K
- William ClutterbuckManchester$4K
- Roshani PatelManchester$3K
- Jessica RyanManchester$3K
- Abhishek ChatterjeeLebanon$659K
- Patricia AutyDover$279K
- Dmytro HavaleshkoDover$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.